Amy Moody is a highly accomplished scientist with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as a Principal Scientist at Avidity Biosciences, Inc. since April 2024, Amy previously held the position of Senior Principal Scientist at Pfizer from February 2019 to April 2024, where responsibilities also included roles as Principal Scientist and Senior Scientist. Prior work includes a Postdoctoral Research Fellowship at Dana-Farber Cancer Institute from February 2016 to January 2019, focused on immune pathway activation in Mycobacterium tuberculosis infections. Amy began their research career as a Research Assistant at the University of Queensland, revealing significant findings in melanoma cell line cultures. Educational credentials include a Ph.D. in Cell, Molecular, and Developmental Biology from Tufts University and a B.A. in Biochemistry from Kenyon College.
This person is not in any teams
This person is not in any offices